Literature DB >> 1810983

Oral cyclosporine for severe chronic idiopathic urticaria and angioedema.

M S Fradin1, C N Ellis, M T Goldfarb, J J Voorhees.   

Abstract

Three patients with chronic urticaria, two of whom also had angioedema, were treated with oral cyclosporine, 6 mg/kg per day. In each patient, complete resolution of symptoms occurred within the first week of therapy; however, all patients eventually had to stop therapy as a result of side effects. On stopping therapy, all side effects resolved and the urticaria and angioedema recurred. Although cyclosporine therapy is not an appropriate treatment of urticaria, the results of this preliminary study suggest that cyclosporine and related drugs should be investigated in the treatment of mast cell-mediated diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1810983     DOI: 10.1016/0190-9622(91)70308-o

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Cyclosporine in chronic idiopathic urticaria with positive autologous serum skin test.

Authors:  K V Godse
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

Review 2.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 3.  Chronic urticaria.

Authors:  A Leznoff
Journal:  Can Fam Physician       Date:  1998-10       Impact factor: 3.275

Review 4.  Urticaria. Recognition, causes and treatment.

Authors:  A D Ormerod
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

5.  Chronic urticaria and treatment options.

Authors:  Kiran Vasant Godse
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

6.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.